Clinical trials
Enrolling by invitation Diabetes Mellitus, Type 1 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 8 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celregen Therapeutics | 1 |
| Dasman Diabetes Institute | 1 |
| Duke University | 1 |
| Hakkari Universitesi | 1 |
| Helsinki University Central Hospital | 1 |
| Hirabai Cowasji Jehangir Medical Research Institute | 1 |
| Lund University | 1 |
| Maccabi Healthcare Services, Israel | 1 |
| Mayo Clinic | 1 |
| Northern Sydney and Central Coast Area Health Service | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 23 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 2 | 2 |
| Hyperemia | 1 |
| Insulin Resistance | 1 |
| Pain | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.